David Smith

David Smith

Chairman at THERACRYF PLC

Net worth: 2 M $ as of 30/09/2026

60 year
Health Technology
Commercial Services
Consumer Services

Profile

Dr. David A. Smith is a Non-Executive Chairman at TheraCryf Plc, an Independent Non-Executive Director at Thalia Therapeutics Plc and a Non-Executive Chairman at SPARTA Biodiscovery Ltd. He is on the Board of Directors at Thalia Therapeutics Plc and Nextmune Laboratories Ltd. Dr. Smith was previously employed as a Chief Executive Officer & Executive Director by Avacta Group Plc, a Chief Executive Officer & Director by Avacta Life Sciences Ltd., and a Director-Institute of Molecular Biophysics by University of Leeds.
He also served on the board at TheraGenetics Ltd. He received his undergraduate degree from The University of Manchester and a doctorate degree from The University of Manchester.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
04/06/2025 15,65,100 ( 0.33% ) 1 M $ 30/09/2026
09/09/2026 3,62,12,888 ( 1.33% ) 86 549 $ 30/09/2026

David Smith active positions

CompaniesPositionStart
THALIA THERAPEUTICS PLC Director/Board Member 08/01/2025
THERACRYF PLC Chairman 19/02/2025
Chairman -
Director/Board Member 06/02/2009

Former positions of David Smith

CompaniesPositionEnd
AVACTA GROUP PLC Founder 01/05/2024
Chief Executive Officer -
Director/Board Member -
Corporate Officer/Principal -
See the detail of David Smith's experience

Education of David Smith

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

52

1st degree connections

9

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies9

Health Services

Consumer Services

Consumer Services

Commercial Services

Health Technology

Commercial Services

Health Technology

Health Technology

Health Technology